Company Filing History:
Years Active: 2014-2021
Title: The Innovative Mind of Thierry Batard
Introduction
Thierry Batard, an accomplished inventor based in Versailles, France, is known for his significant contributions to the field of biotechnology. With an impressive portfolio of five patents, Batard focuses on improving human health through innovative solutions, particularly in the areas of allergy and inflammation treatment.
Latest Patents
Batard's latest patents are a testament to his research prowess and innovative thinking. One notable invention is the "Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids." This invention addresses the risks associated with grass pollen extracts by minimizing the presence of flavonoid glycosides, which can contribute to genotoxicity when activated by enzymes in pollen. The method involves ultrafiltration to create safer grass pollen extracts.
Another significant patent is focused on "Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa." This invention explores the application of IgG-type immunoglobulins and CD32 receptor ligands to treat various inflammatory conditions, including allergic asthma, emphasizing administration via mucosal routes for improved efficacy.
Career Highlights
Throughout his career, Batard has worked with reputable companies, including Stallergenes and Stallergenes S.A., where he has developed practical solutions for allergy sufferers. His research and development efforts have positioned him as a key player in the biotechnology sector.
Collaborations
In his journey, Batard has collaborated with notable professionals like Philippe Moingeon and Emmanuel Nony. These partnerships have facilitated innovative breakthroughs and enhanced the impact of his inventions within the scientific community.
Conclusion
Thierry Batard's inventive spirit and dedication to advancing health solutions have led to significant innovations in biotechnology. His patented inventions underscore his commitment to improving quality of life for individuals affected by allergies and inflammatory diseases. As he continues his work, the potential for new advancements remains promising, making him a noteworthy figure in his field.